Cite
APA Citation
Hirsh Raccah, B., Yanovsky, A., Treves, N., Rotshild, V., Renoux, C., Danenberg, H., Eliaz, R., & Matok, I. (2021). proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression. International journal of cardiology, 335, 7–14. http://access.bl.uk/ark:/81055/vdc_100132604796.0x000047